Tysabri Clinical Trials Tysabri RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study for Tysabri Participant Preference
Condition:   Relapsing-Remitting Multiple Sclerosis (RRMS) Intervention:   Drug: Natalizumab Sponsor:   Biogen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials